117502 ⎘
Carbon-carbon lyases (4.1); Carboxy-lyases (4.1.1) Glutamate decarboxylase (4.1.1.15)
IMMUNOTHERAPY
#2TOLEROGENIC PEPTIDES
#3PLATFORM FOR BIO-BASED PRODUCTION OF HIGH LEVELS OF O-PHOSPHOSERINE, CYSTEATE, OR TAURINE
#4MODULATION OF THE GUT MICROBIOME TO TREAT MENTAL DISORDERS OR DISEASES OF THE CENTRAL NERVOUS SYSTEM
#5Viral Vector Encoding GAD For Treating Spasticity
#6INHIBITORY NEURON-SPECIFIC PROMOTER
#7COMPOSITION FOR PREVENTING OR TREATING DEGENERATIVE BRAIN DISEASES
#8MHC IB-MEDIATED ISLET-ANTIGEN-SPECIFIC IMMUNOSUPPRESSION AS A NOVEL TREATMENT FOR TYPE 1 DIABETES
#9Viral Vectors For Treating Neurogenic Detrusor Overactivity
#10TOBACCO PLANTS HAVING INCREASED NITROGEN EFFICIENCY AND METHODS OF USING SUCH PLANTS
#11BACTERIA PRODUCING GAMMA-AMINOBUTYRIC ACID (GABA) AND USES OF THE BACTERIA
#12PROCESS FOR PRODUCING TAURINE
#13VIRUS TO EXPRESS GAD65 UNDER E2 REGULATORY ELEMENT
#14MHC CLASS II T-CELL MODULATORY MULTIMERIC POLYPEPTIDES FOR TREATING TYPE 1 DIABETES MELLITUS (T1D) AND METHODS OF USE THEREOF
#15Viral Vectors For Treating Neurogenic Detrusor Overactivity
#16Antigen-Presenting Polypeptides with Chemical Conjugation Sites and Methods of Use Thereof
#17Viral Vectors For Treating Neurogenic Detrusor Overactivity
#18GLUTAMATE DECARBOXYLASE MUTANT WITH IMPROVED PH TOLERANCE AND USE THEREOF IN SYNTHESIS OF GAMMA-AMINOBUTYRIC ACID
#19MHC CLASS II T-CELL MODULATORY POLYPEPTIDES FOR TREATING TYPE 1 DIABETES MELLITUS (T1D) AND METHODS OF USE THEREOF
#20MESOPHILIC, METHYLOTROPHIC BACTERIA FOR THE PH-INDEPENDENT PRODUCTION OF BIOCHEMICALS
#21IMMUNOGENIC PEPTIDES AND THEIR USE IN IMMUNE DISORDERS
#22MHC class II T-cell modulatory multimeric polypeptides for treating type 1 diabetes mellitus (T1D) and methods of use thereof
#23MHC CLASS II T-CELL MODULATORY MULTIMERIC POLYPEPTIDES FOR TREATING TYPE 1 DIABETES MELLITUS (T1D) AND METHODS OF USE THEREOF
#24VIRAL VECTORS FOR TREATING NEUROGENIC DETRUSOR OVERACTIVITY
#25CARBON DIOXIDE GENERATION
#26Tobacco plants having increased nitrogen efficiency and methods of using such plants
#27MODULATION OF THE GUT MICROBIOME TO TREAT MENTAL DISORDERS OR DISEASES OF THE CENTRAL NERVOUS SYSTEM
#28METHODS FOR PROMOTING PANCREATIC ISLET CELL GROWTH
#29IMPROVED IMMUNOTHERAPY
#30METHODS FOR PROMOTING PANCREATIC ISLET CELL GROWTH
#31Immunogenic peptides and their use in immune disorders
#32Novel Combinations for Antigen Based Therapy
#33Viral vectors for treating neurogenic detrusor overactivity
#34COMPOSITION FOR ALLEVIATING OR TREATING PAIN
#35METHODS AND MATERIALS FOR THE BIOSYNTHESIS OF COMPOUNDS INVOLVED IN GLUTAMATE METABOLISM AND DERIVATIVES AND COMPOUNDS RELATED THERETO
#36Method for delivery of biological molecule to nervous tissue
#37Method and composition for treating neuronal hyper-excitabtiity
#38Modulation of the gut microbiome to treat mental disorders or diseases of the central nervous system
#39Methods and materials for the production of monomers for nylon-4/polyester production
#40Signal peptide, L-glutamic acid synthesized using konjac flour and methods of using same
#41Method for preparing biobased nylon: polylactam
#42Tobacco plants having increased nitrogen efficiency and methods of using such plants
#43Detection of autoantibodies reactive with pancreatic islet cell antigenic molecules and/or insulin
#44Detection of autoantibodies reactive with pancreatic islet cell antigenic molecules and/or insulin
#45Host cell modified to produce 2-pyrrolidone
#46Methods and materials for the production of monomers for nylon-4/polyester production
#47Immunogenic peptides and their use in immune disorders
#48METHOD AND COMPOSITION FOR TREATING SPASTICITY
#49Genetically engineered yeast
#50Materials and methods for modulating immune responses
#51Detection of autoantibodies reactive with pancreatic islet cell antigenic molecules and/or insulin
#52Immunogenic peptides and their use in immune disorders
#53Cell line
#54Novel glutamic acid decarboxylase (GAD) proteins and methods of use
#55COMPOSITION FOR ATTENUATING NEUROPATHIC PAIN COMPRISING A RECOMBINANT VENTOR EXPRESSING GAD65
#56Peripherally delivered glutamic acid decarboxylase gene therapy for spinal cord injury pain
#57Herpes simplex virus vector
#58Method for preventing or delaying the onset of diabetes
#59Chimeric proteins for diagnosis and treatment of diabetes
#60Chimeric insulin-gad proteins for treating patients with type 1 diabetes or at risk of developing type 1 diabetes
#61Chimeric proteins for diagnosis and treatment of diabetes
#62Method of delaying the onset of diabetes
#63Nucleic acid encoding GAD65
#64Detection of autoantibodies reactive with pancreatic islet cell antigenic molecules and/or insulin